The SCAN domain is required for the full transcriptional activity of MZF1, whereas the SCAN-only factor SCAND1 is powerfully associated with chromatin and represses the tumorigenesis of prostate cancer cells. The gene discussed is SCAND1; the disease is prostate carcinoma.